Heart drugs miss the mark despite hitting key targets
Two heart drugs—pelacarsen and ziltivekimab—missed the mark in large trials despite targeting key cardiovascular risk markers like lipoprotein(a) levels.
Two heart drugs—pelacarsen and ziltivekimab—missed the mark in large trials despite targeting key cardiovascular risk markers like lipoprotein(a) levels.
Indonesia’s BRIN urges cybersecurity firms to collaborate on quantum computing research to safeguard data against future threats.
Two heart drugs—pelacarsen and ziltivekimab—missed the mark in large trials despite targeting key cardiovascular risk markers like lipoprotein(a)…
Metro PR finds success through adaptation and self-reliance, led by founder Tess Finkle.
Waymo may launch its own ride hailing app in major cities like Phoenix and Austin.
Zapier’s clear hiring communication keeps candidates engaged, with responses within seven days and salary transparency to reduce stress…